Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Solid Tumor

NCT03658785 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT03658785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03658785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Solid Tumor
Lead sponsor
Tongji Hospital
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 28, 2020
Completion date
December 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic cancer, recurrence tumor, solid tumor